iRhythm to Acquire VitalConnect for $287.5M in Cash and Stock
IRTC sits 29% above its 52-week low of $100.846 on elevated volume (2.1× avg).
Summary
iRhythm Holdings announced the acquisition of Vital Connect for $287.5 million, combining cash and stock, to expand its cardiac monitoring platform. The deal is expected to close by end of 2026.
Key Events · M&A and Partnerships · IRTC
-
Acquisition of Vital Connect
iRhythm entered into a definitive agreement to acquire Vital Connect, Inc. for $237.5 million in cash and $50 million in iRhythm common stock, with the deal expected to close by the end of 2026.
-
Strategic Rationale
The acquisition adds Vital Connect's remote patient monitoring technology to iRhythm's cardiac monitoring platform, expanding its product portfolio and addressable market.
-
Interim Funding
iRhythm will provide up to $30 million in interim funding to Vital Connect to support operations before the deal closes.
-
Reverse Termination Fee
iRhythm agreed to pay a $9 million reverse termination fee if the deal is terminated due to failure to obtain required antitrust approvals.
Analysis · IRTC · Industrial Applications And Services
iRhythm Holdings is acquiring Vital Connect, a digital health company, for $237.5 million in cash and $50 million in iRhythm stock. The deal expands iRhythm's cardiac monitoring platform and adds complementary remote patient monitoring capabilities. The acquisition is expected to close by the end of 2026, subject to antitrust clearance and other conditions. iRhythm will also provide up to $30 million in interim funding to Vital Connect before closing. The $9 million reverse termination fee protects Vital Connect if the deal fails due to antitrust issues. This is a significant strategic move for iRhythm, which recently reported strong Q2 results and settled a patent litigation for $50 million.
At the time of this filing, IRTC was trading at $130.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $100.85 to $212.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.